Post-quantum cryptography standards highlight the need for governments to prepare for emerging quantum computing risks. Previously considered a distant concern, quantum computers may soon compromise the government’s most sensitive data. Here's how to get ready.
Davide Villa, business development director for EMEAI at Western Digital, discusses the data storage challenges in the healthcare industry and how they can be addressed.
An Australian team found that antibodies created by infection with the virus are not effective against COVID variants - suggesting that vaccination gives stronger protection.
The Lambda variant, originating in Peru, has been found in 32 countries - but for the moment, it remains classified as a less threatening Variant of Interest.
SAGE say the UK Governments' plans to lift all social distancing measures on 19 July are too much - they believe a rise in infections will increase ethnic minority COVID deaths.
While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.
A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.
A study on New York City neighbourhoods found that "neighbourhood disadvantage", a mix of inequality measurements, is connected to a higher rate of COVID-19 cases.
Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.
The World Health Organisation says that double-vaccinated people should wear masks due to the rising threat of the Delta variant, as the UK considers dropping mandatory mask measures after 'unlockdown'.
Astrophysicists have argued for ten years about the speed of the universe expanding - now, a study by Wendy Freedman at the University of Chicago finds that the standard model could be close to the truth.
According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.
Vihan Sharma, Managing Director Europe, LiveRamp, explores why the lockdown pushed Britain’s high street to a tipping point and why we’ll be better for it.
